Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists discover new ‘jumping’ superbug gene
“In treatments, if colistin does not work, it literally could mean death for patients. If colistin resistance spreads, a lot of people will die.”
mcr-9 can cause resistance to colistin 

US food scientists have discovered mcr-9, a new ‘jumping gene’ that can cause resistance to the last resort antibiotic colistin.

Cornell University researchers found mcr-9 in the genome of a strain of salmonella. To their surprise, the salmonella strain did not show colistin resistance.

However, when the gene was inserted into a non-pathogenic strain of E coli, researchers were able to ‘turn on’ mcr-9, making the strain resistant to colistin.

The findings have been published in the journal Mbio.

Co-lead author Laura Carroll said: “When we originally tested the salmonella isolate and found that it wasn’t resistant to colistin, we were perplexed. But when [co-lead author Ahmed Gabella] cloned it into an E. coli host, he was able to find that the gene could confer resistance to colistin.”

Commenting on the findings, Professor Martin Wiedmann said: “In treatments, if colistin does not work, it literally could mean death for patients. If colistin resistance spreads, a lot of people will die.”

mcr-9 is the latest in a string of ‘mobilised colistin-resistance genes’ first discovered in 2015.

The National Centre for Biotechnology Information added details of the new gene to its database, so that it can be used to identify the gene in bacteria isolated from food and people.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.